Apheresis Devices Market by Product and Geography - Forecast and Analysis 2020-2024
SKU ID :TNV-14208418 | Published Date: 19-Nov-2019 | No. of pages: 151Description
TOC
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Systems - Market size and forecast 2019-2024
• Consumables - Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advances
• Business strategies
• Growth in new indications for plasma products
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Asahi Kasei Corp.
• B. Braun Melsungen AG
• Cerus Corp.
• Fresenius Medical Care AG & Co. KGaA
• Haemonetics Corp.
• HemaCare Corp.
• Kaneka Corp.
• Kawasumi Laboratories Inc.
• Nikkiso Co. Ltd.
• Terumo Corp.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Product overview
Exhibit 02: Global healthcare equipment market
Exhibit 03: Segments of global healthcare equipment market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Systems - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Systems - Year-over-year growth 2020-2024 (%)
Exhibit 22: Consumables - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Consumables - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details and market impact analysis
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Business strategies and their market impact analysis
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Asahi Kasei Corp. - Vendor overview
Exhibit 47: Asahi Kasei Corp. - Product segments
Exhibit 48: Asahi Kasei Corp. - Organizational developments
Exhibit 49: Asahi Kasei Corp. - Geographic focus
Exhibit 50: Asahi Kasei Corp. - Segment focus
Exhibit 51: Asahi Kasei Corp. - Key offerings
Exhibit 52: Asahi Kasei Corp. - Key customers
Exhibit 53: B. Braun Melsungen AG - Vendor overview
Exhibit 54: B. Braun Melsungen AG - Business segments
Exhibit 55: B. Braun Melsungen AG - Organizational developments
Exhibit 56: B. Braun Melsungen AG - Geographic focus
Exhibit 57: B. Braun Melsungen AG - Segment focus
Exhibit 58: B. Braun Melsungen AG - Key offerings
Exhibit 59: B. Braun Melsungen AG - Key customers
Exhibit 60: Cerus Corp. - Vendor overview
Exhibit 61: Cerus Corp. - Business segments
Exhibit 62: Cerus Corp. - Organizational developments
Exhibit 63: Cerus Corp. - Geographic focus
Exhibit 64: Cerus Corp. - Key offerings
Exhibit 65: Cerus Corp. - Key customers
Exhibit 66: Fresenius Medical Care AG & Co. KGaA - Vendor overview
Exhibit 67: Fresenius Medical Care AG & Co. KGaA - Business segments
Exhibit 68: Fresenius Medical Care AG & Co. KGaA - Organizational developments
Exhibit 69: Fresenius Medical Care AG & Co. KGaA - Geographic focus
Exhibit 70: Fresenius Medical Care AG & Co. KGaA - Segment focus
Exhibit 71: Fresenius Medical Care AG & Co. KGaA - Key offerings
Exhibit 72: Fresenius Medical Care AG & Co. KGaA - Key customers
Exhibit 73: Haemonetics Corp. - Vendor overview
Exhibit 74: Haemonetics Corp. - Business segments
Exhibit 75: Haemonetics Corp. - Organizational developments
Exhibit 76: Haemonetics Corp. - Geographic focus
Exhibit 77: Haemonetics Corp. - Segment focus
Exhibit 78: Haemonetics Corp. - Key offerings
Exhibit 79: Haemonetics Corp. - Key customers
Exhibit 80: HemaCare Corp. - Vendor overview
Exhibit 81: HemaCare Corp. - Product segments
Exhibit 82: HemaCare Corp. - Organizational developments
Exhibit 83: HemaCare Corp. - Key offerings
Exhibit 84: HemaCare Corp. - Key customers
Exhibit 85: Kaneka Corp. - Vendor overview
Exhibit 86: Kaneka Corp. - Business segments
Exhibit 87: Kaneka Corp. - Organizational developments
Exhibit 88: Kaneka Corp. - Geographic focus
Exhibit 89: Kaneka Corp. - Segment focus
Exhibit 90: Kaneka Corp. - Key offerings
Exhibit 91: Kaneka Corp. - Key customers
Exhibit 92: Kawasumi Laboratories Inc. - Vendor overview
Exhibit 93: Kawasumi Laboratories Inc. - Business segments
Exhibit 94: Kawasumi Laboratories Inc. - Key offerings
Exhibit 95: Kawasumi Laboratories Inc. - Key customers
Exhibit 96: Nikkiso Co. Ltd. - Vendor overview
Exhibit 97: Nikkiso Co. Ltd. - Business segments
Exhibit 98: Nikkiso Co. Ltd. - Geographic focus
Exhibit 99: Nikkiso Co. Ltd. - Segment focus
Exhibit 100: Nikkiso Co. Ltd. - Key offerings
Exhibit 101: Nikkiso Co. Ltd. - Key customers
Exhibit 102: Terumo Corp. - Vendor overview
Exhibit 103: Terumo Corp. - Business segments
Exhibit 104: Terumo Corp. - Organizational developments
Exhibit 105: Terumo Corp. - Geographic focus
Exhibit 106: Terumo Corp. - Segment focus
Exhibit 107: Terumo Corp. - Key offerings
Exhibit 108: Terumo Corp. - Key customers
Exhibit 109: Validation techniques employed for market sizing
Exhibit 110: Definition of market positioning of vendors
Tables & Figures
Companies
Asahi Kasei Corp., B. Braun Melsungen AG, Cerus Corp., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corp., HemaCare Corp., Kaneka Corp., Kawasumi Laboratories Inc., Nikkiso Co. Ltd., and Terumo Corp.
- PRICE
-
$2500$4000